Search Close Search
Search Close Search
Page Menu

News

Getting Results…
  • Andreas Bergmann, PhD, receives Outstanding Investigator Award from NIH

    Andreas Bergmann, PhD, receives Outstanding Investigator Award from NIH

    Andreas Bergmann, PhD, has received a five-year, $3.5 million Maximizing Investigators' Research Award from the National Institutes of Health.

    Read more
  • Craig Peterson receives $4.5 million outstanding investigator award from NIH

    Craig Peterson receives $4.5 million outstanding investigator award from NIH

    UMass Medical School scientist Craig L. Peterson, PhD, has received a five-year, $4.5 million Maximizing Investigators' Research Award (MIRA) from the National Institutes of Health for research that explores the role chromosome structure plays in regulating gene expression, DNA repair and DNA fidelity during cell division.

    Read more
  • PhD candidate Yvonne Chan a ‘protein engineer’

    PhD candidate Yvonne Chan a ‘protein engineer’

    In this Women in Science video, PhD candidate Yvonne Chan talks about her exploration of how proteins fold and maintain their three-dimensional structure.

    Read more
  • New genome-editing strategy developed at UMMS may lead to therapeutics

    New genome-editing strategy developed at UMMS may lead to therapeutics

    Researchers at UMass Medical School have developed a genome-editing strategy to correct disease-causing DNA mutations in mouse models of human genetic diseases. Dan Wang, PhD, is first author and Guangping Gao, PhD, is a co-corresponding author on the paper published in the Aug. 18 edition of Nature Biotechnology.

    Read more
  • Guangping Gao named a top translational scientist by Nature Biotechnology

    Guangping Gao named a top translational scientist by Nature Biotechnology

    Guangping Gao, PhD, has been ranked one of the world’s top translational researchers, according to a new tabulation from Nature Biotechnology. The Top 20 Translational Researchers of 2017, published this month by Nature Biotechnology, places Dr. Gao fourth.

    Read more
  • Job Dekker and colleagues develop new model to examine large mutations in cells

    Job Dekker and colleagues develop new model to examine large mutations in cells

    Job Dekker, PhD, creator of high-throughput chromosome conformation capture (known as Hi-C), and a team of researchers have developed a new computational framework combining optical mapping, Hi-C, and whole genome sequencing to find what are called “structural variants” within cancer genomes and learn more about how such cancers begin.

    Read more
  • UMass Medical School magazine debuts

    UMass Medical School magazine debuts

    As part of UMass Medical School’s ongoing initiatives to share news about the research, academic and service achievements that take place every day on our campuses, a new magazine debuts this week, @umassmed.

    Read more
  • GSBS recognizes 52 graduate students as they embark on dissertation research

    GSBS recognizes 52 graduate students as they embark on dissertation research

    Graduate School of Biomedical Sciences Dean Mary Ellen Lane, PhD, welcomed and congratulated 52 graduate students entering the transformative years of their doctoral research during the GSBS Qualifying Exam Recognition Ceremony on Tuesday, Sept. 18.

    Read more
  • Brian Kelch lab to bring biomedical science lessons to Worcester Technical High School

    Brian Kelch lab to bring biomedical science lessons to Worcester Technical High School

    Students from the lab of Brian Kelch, PhD, will share their biomedical training and laboratory experience with students at Worcester Technical High School, thanks to a 5-year, $1 million grant to study viral motors from the National Science Foundation.

    Read more
  • UMass Chan study identifies potential on/off switch for HIV-1

    UMMS study identifies potential on/off switch for HIV-1

    Research from the lab of Jeremy Luban, MD, suggests targeting the HUSH complex to activate HIV-1 may be an avenue for making latent viral reservoirs susceptible to antiviral therapies.

    Read more
  • Rodrigo Lopez Gonzalez awarded Alzheimer’s Association Research Fellowship

    Rodrigo Lopez Gonzalez awarded Alzheimer’s Association Research Fellowship

    Rodrigo Lopez Gonzalez, PhD, has been awarded the 2019 Alzheimer’s Association Research Fellowship to Promote Diversity. 

    Read more
  • Postdoc Tessa Simone explores role of immune cells in cancer

    Postdoc Tessa Simone explores role of immune cells in cancer

    Tessa Simone, PhD, a postdoc in the lab of Michael R. Green, MD, PhD, is focused on identifying ways to teach the immune system to attack cancerous tumors without harming healthy tissue. Learn about her research  in the latest Women in Science video.

    Read more
  • Silvia Corvera, Michael Czech receive $2.5M grant to advance potential therapy for type 2 diabetes

    Silvia Corvera, Michael Czech receive $2.5M grant to advance potential therapy for type 2 diabetes

    Silvia Corvera, MD, and Michael Czech, PhD, are investigating whether technologies developed in their labs will harness beige fat’s ability to burn energy and accelerate metabolism in order to improve the body’s response to sugar and lower blood glucose levels.

    Read more
  • UMass Medical School scientists safely deliver RNAi-based gene therapy for ALS in animal model

    UMass Medical School scientists safely deliver RNAi-based gene therapy for ALS in animal model

    A gene therapy delivered to motor neurons was able to silence SOD1 protein, mutations of which are linked to ALS, without causing any adverse effects, according to a new study published in Science Translational Medicine, by Christian Mueller, PhD, and Robert H. Brown Jr., DPhil, MD.

    Read more
  • Blu Genes Foundation gives UMMS $1.4M to bring Tay-Sachs gene therapy to clinical trial

    Blu Genes Foundation gives UMMS $1.4M to bring Tay-Sachs gene therapy to clinical trial

    The Toronto-based Blu Genes Foundation, which is dedicated to developing gene therapies for rare disease, has given $1.4 million to UMass Medical School to advance a Phase I/II clinical trial for Tay-Sachs. Miguel Sena-Esteves, PhD, Terence Flotte, MD, Heather Gray-Edwards, PhD, DVM, and colleagues at  Auburn University are leading the research.

    Read more